{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:48:31Z","timestamp":1792014511902,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0H3716N"],"award-info":[{"award-number":["G0H3716N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41393-026-01262-6","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:48:12Z","timestamp":1787222892000},"page":"883-893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NAD+ supplementation and PARP inhibition following spinal cord injury in mice: Hurdles and considerations for therapeutic use"],"prefix":"10.1038","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5730-5225","authenticated-orcid":false,"given":"Elle E. M.","family":"Scheijen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7816-023X","authenticated-orcid":false,"given":"Naomi","family":"Veeningen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8945-0395","authenticated-orcid":false,"suffix":"III","given":"David M","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"1262_CR1","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3390\/antiox11091728","volume":"11","author":"EEM Scheijen","year":"2022","unstructured":"Scheijen EEM, Hendrix S, Wilson DM. Oxidative DNA damage in the pathophysiology of spinal cord injury: seems obvious, but where is the evidence? Antioxidants. 2022;11:1728.","journal-title":"Antioxidants"},{"key":"1262_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40265-015-0345-6","volume":"75","author":"ED Deeks","year":"2015","unstructured":"Deeks ED. Olaparib: first global approval. Drugs. 2015;75:231\u201340.","journal-title":"Drugs"},{"key":"1262_CR3","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1200\/JCO.22.01003","volume":"40","author":"BJ Monk","year":"2022","unstructured":"Monk BJ, Parkinson C, Lim MC, O\u2019Malley DM, Oaknin A, Wilson MK, et al. A randomized, Phase III trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA-MONO\/GOG-3020\/ENGOT-ov45). J Clin Oncol. 2022;40:3952\u201364.","journal-title":"J Clin Oncol"},{"key":"1262_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/ijgc-2022-004079","volume":"33","author":"BJ Monk","year":"2023","unstructured":"Monk BJ, Gonz\u00e1lez-Martin A, Buckley L, Matulonis UA, Rimel BJ, Wu X, et al. Safety and management of niraparib monotherapy in ovarian cancer clinical trials. Int J Gynecol Cancer. 2023;33:971\u201381.","journal-title":"Int J Gynecol Cancer"},{"key":"1262_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00280-023-04600-0","volume":"93","author":"A Mittra","year":"2024","unstructured":"Mittra A, Coyne G, Zlott J, Kummar S, Meehan R, Rubinstein L, et al. Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors. Cancer Chemother Pharmacol. 2024;93:177\u201389.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1262_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1101\/gad.335109.119","volume":"34","author":"MS Cohen","year":"2020","unstructured":"Cohen MS. Interplay between compartmentalized NAD<SUP>+<\/SUP> synthesis and consumption: a focus on the PARP family. Genes Dev. 2020;34:254\u201362.","journal-title":"Genes Dev"},{"key":"1262_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature20790","volume":"541","author":"NC Hoch","year":"2017","unstructured":"Hoch NC, Hanzlikova H, Rulten SL, T\u00e9treault M, Komulainen E, Ju L, et al. XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature. 2017;541:87\u201391.","journal-title":"Nature"},{"key":"1262_CR8","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1158\/0008-5472.CAN-09-4716","volume":"70","author":"P Gottipati","year":"2010","unstructured":"Gottipati P, Vischioni B, Schultz N, Solomons J, Bryant HE, Djureinovic T, et al. Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells. Cancer Res. 2010;70:5389\u201398.","journal-title":"Cancer Res"},{"key":"1262_CR9","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051851","volume":"22","author":"E Komulainen","year":"2021","unstructured":"Komulainen E, Badman J, Rey S, Rulten S, Ju L, Fennell K, et al. Parp1 hyperactivity couples DNA breaks to aberrant neuronal calcium signalling and lethal seizures. EMBO Rep. 2021;22:e51851.","journal-title":"EMBO Rep"},{"key":"1262_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118975","volume":"267","author":"K Thapa","year":"2021","unstructured":"Thapa K, Khan H, Sharma U, Grewal AK, Singh TG. Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases. Life Sci. 2021;267:118975.","journal-title":"Life Sci"},{"key":"1262_CR11","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/s41556-023-01280-z","volume":"25","author":"SHN Munk","year":"2023","unstructured":"Munk SHN, Merchut-Maya JM, Adelantado Rubio A, Hall A, Pappas G, Milletti G, et al. NAD+ regulates nucleotide metabolism and genomic DNA replication. Nat Cell Biol. 2023;25:1774\u201386.","journal-title":"Nat Cell Biol"},{"key":"1262_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102037","volume":"298","author":"JA Ruszkiewicz","year":"2022","unstructured":"Ruszkiewicz JA, B\u00fcrkle A, Mangerich A. Fueling genome maintenance: On the versatile roles of NAD(+) in preserving DNA integrity. J Biol Chem. 2022;298:102037.","journal-title":"J Biol Chem"},{"key":"1262_CR13","doi-asserted-by":"publisher","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","volume":"115","author":"Y Hou","year":"2018","unstructured":"Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau DL, Zavala E, et al. NAD(+) supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci USA. 2018;115:E1876\u2013e85.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1262_CR14","doi-asserted-by":"publisher","first-page":"e2011226118","DOI":"10.1073\/pnas.2011226118","volume":"118","author":"Y Hou","year":"2021","unstructured":"Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S, et al. NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer\u2019s disease via cGAS-STING. Proc Natl Acad Sci USA. 2021;118:e2011226118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1262_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cmet.2016.09.004","volume":"24","author":"EF Fang","year":"2016","unstructured":"Fang EF, Kassahun H, Croteau DL, Scheibye-Knudsen M, Marosi K, Lu H, et al. NAD(+) replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 2016;24:566\u201381.","journal-title":"Cell Metab"},{"key":"1262_CR16","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1097\/j.pain.0000000000001924","volume":"161","author":"MV Hamity","year":"2020","unstructured":"Hamity MV, White SR, Blum C, Gibson-Corley KN, Hammond DL. Nicotinamide riboside relieves paclitaxel-induced peripheral neuropathy and enhances suppression of tumor growth in tumor-bearing rats. Pain. 2020;161:2364\u201375.","journal-title":"Pain"},{"key":"1262_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12929-024-01104-8","volume":"32","author":"EEM Scheijen","year":"2025","unstructured":"Scheijen EEM, Veeningen N, Duw\u00e9 S, Ivanova A, Van Broeckhoven J, Hendrix S, et al. Temporal and spatial pattern of DNA damage in neurons following spinal cord Injury in mice. J Biomed Sci. 2025;32:12.","journal-title":"J Biomed Sci"},{"key":"1262_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1124\/jpet.104.076711","volume":"312","author":"T Genovese","year":"2005","unstructured":"Genovese T, Mazzon E, Mui\u00e0 C, Patel NSA, Threadgill MD, Bramanti P, et al. Inhibitors of Poly(ADP-Ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther. 2005;312:449\u201357.","journal-title":"J Pharmacol Exp Ther"},{"key":"1262_CR19","first-page":"12207","volume":"8","author":"X Meng","year":"2015","unstructured":"Meng X, Song W, Deng B, Xing Z, Zhang W. 3-aminobenzamide, one of poly(ADP-ribose)polymerase-1 inhibitors, rescuesapoptosisin rat models of spinal cord injury. Int J Clin Exp Pathol. 2015;8:12207\u201315.","journal-title":"Int J Clin Exp Pathol"},{"key":"1262_CR20","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1016\/j.wneu.2019.03.116","volume":"127","author":"W Zhao","year":"2019","unstructured":"Zhao W, Li H, Hou Y, Jin Y, Zhang L. Combined administration of Poly-ADP-Ribose Polymerase-1 and Caspase-3 inhibitors alleviates neuronal apoptosis after spinal cord injury in rats. World Neurosurg. 2019;127:e346\u201352.","journal-title":"World Neurosurg"},{"key":"1262_CR21","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1007\/s12035-020-02033-x","volume":"57","author":"G Casili","year":"2020","unstructured":"Casili G, Campolo M, Lanza M, Filippone A, Scuderi S, Messina S, et al. Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) inhibitor in countering autophagy and apoptotic processes associated to spinal cord injury. Mol Neurobiol. 2020;57:4394\u2013407.","journal-title":"Mol Neurobiol"},{"key":"1262_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/neu.2008.0692","volume":"26","author":"KL Wu","year":"2009","unstructured":"Wu KL, Hsu C, Chan JY. Nitric oxide and superoxide anion differentially activate poly(ADP-ribose) polymerase-1 and Bax to induce nuclear translocation of apoptosis-inducing factor and mitochondrial release of cytochrome c after spinal cord injury. J Neurotrauma. 2009;26:965\u201377.","journal-title":"J Neurotrauma"},{"key":"1262_CR23","doi-asserted-by":"crossref","unstructured":"Wang X, Sekine Y, Byrne AB, Cafferty WB, Hammarlund M, Strittmatter SM Inhibition of Poly-ADP-Ribosylation fails to increase axonal regeneration or improve functional recovery after adult mammalian CNS injury. eNeuro. 2016;3:476\u201383.","DOI":"10.1523\/ENEURO.0270-16.2016"},{"key":"1262_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1323566","volume":"17","author":"C Zhang","year":"2023","unstructured":"Zhang C, Li Y, Bai F, Talifu Z, Ke H, Xu X, et al. The identification of new roles for nicotinamide mononucleotide after spinal cord injury in mice: an RNA-seq and global gene expression study. Front Cell Neurosci. 2023;17:1323566.","journal-title":"Front Cell Neurosci"},{"key":"1262_CR25","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/cimb46020082","volume":"46","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang C, Li Z, Bai F, Jing Y, Ke H, et al. Nicotinamide riboside regulates chemotaxis to decrease inflammation and ameliorate functional recovery following spinal cord injury in mice. Curr Issues Mol Biol. 2024;46:1291\u2013307.","journal-title":"Curr Issues Mol Biol"},{"key":"1262_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.expneurol.2023.114479","volume":"368","author":"M Metcalfe","year":"2023","unstructured":"Metcalfe M, David BT, Langley BC, Hill CE. Elevation of NAD plus by nicotinamide riboside spares spinal cord tissue from injury and promotes locomotor recovery. Exp Neurol. 2023;368:10.","journal-title":"Exp Neurol"},{"key":"1262_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/neu.2006.23.635","volume":"23","author":"DM Basso","year":"2006","unstructured":"Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 2006;23:635\u201359.","journal-title":"J Neurotrauma"},{"key":"1262_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.","journal-title":"Sci Rep"},{"key":"1262_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"1262_CR30","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/ijms23084142","volume":"23","author":"EEM Scheijen","year":"2022","unstructured":"Scheijen EEM, Wilson DM. Genome integrity and neurological disease. Int J Mol Sci. 2022;23:4142.","journal-title":"Int J Mol Sci"},{"key":"1262_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111189","volume":"87-88","author":"KL Seldeen","year":"2021","unstructured":"Seldeen KL, Shahini A, Thiyagarajan R, Redae Y, Leiker M, Rajabian N, et al. Short-term nicotinamide riboside treatment improves muscle quality and function in mice and increases cellular energetics and differentiating capacity of myogenic progenitors. Nutrition. 2021;87-88:111189.","journal-title":"Nutrition"},{"key":"1262_CR32","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0960327115626254","volume":"35","author":"D Conze","year":"2016","unstructured":"Conze D, Crespo-Barreto J, Kruger C. Safety assessment of nicotinamide riboside, a form of vitamin B3. Hum Exp Toxicol. 2016;35:1149\u201360.","journal-title":"Hum Exp Toxicol"},{"key":"1262_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1167\/iovs.61.10.47","volume":"61","author":"X Zhang","year":"2020","unstructured":"Zhang X, Henneman NF, Girardot PE, Sellers JT, Chrenek MA, Li Y, et al. Systemic treatment with nicotinamide riboside is protective in a mouse model of light-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2020;61:47.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1262_CR34","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/STROKEAHA.110.594861","volume":"42","author":"F Liu","year":"2011","unstructured":"Liu F, Lang J, Li J, Benashski SE, Siegel M, Xu Y, et al. Sex differences in the response to poly(ADP-ribose) polymerase-1 deletion and caspase inhibition after stroke. Stroke. 2011;42:1090\u20136.","journal-title":"Stroke"},{"key":"1262_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbi.2018.05.022","volume":"73","author":"C Charriaut-Marlangue","year":"2018","unstructured":"Charriaut-Marlangue C, Leconte C, Csaba Z, Chafa L, Pansiot J, Talatizi M, et al. Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal stroke. Brain Behav Immun. 2018;73:375\u201389.","journal-title":"Brain Behav Immun"},{"key":"1262_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","volume":"34","author":"B Brakedal","year":"2022","unstructured":"Brakedal B, D\u00f6lle C, Riemer F, Ma Y, Nido GS, Skeie GO, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease. Cell Metab. 2022;34:396\u2013407.e6.","journal-title":"Cell Metab"},{"key":"1262_CR37","first-page":"2284","volume":"92","author":"RPR Nanga","year":"2024","unstructured":"Nanga RPR, Wiers CE, Elliott MA, Wilson NE, Liu F, Cao Q, et al. Acute nicotinamide riboside supplementation increases human cerebral NAD+ levels in vivo. Magn Reson Med. 2024;92:2284\u201393.","journal-title":"Magn Reson Med"},{"key":"1262_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.expneurol.2017.03.012","volume":"292","author":"K Chen","year":"2017","unstructured":"Chen K, Marsh BC, Cowan M, Al\u2019Joboori YD, Gigout S, Smith CC, et al. Sequential therapy of anti-Nogo-A antibody treatment and treadmill training leads to cumulative improvements after spinal cord injury in rats. Exp Neurol. 2017;292:135\u201344.","journal-title":"Exp Neurol"},{"key":"1262_CR39","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.1523\/JNEUROSCI.0983-11.2011","volume":"31","author":"D Wang","year":"2011","unstructured":"Wang D, Ichiyama RM, Zhao R, Andrews MR, Fawcett JW. Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J Neurosci. 2011;31:9332\u201344.","journal-title":"J Neurosci"},{"key":"1262_CR40","doi-asserted-by":"publisher","first-page":"e6862","DOI":"10.1371\/journal.pone.0006862","volume":"4","author":"R Ichiyama","year":"2009","unstructured":"Ichiyama R, Potuzak M, Balak M, Kalderon N, Edgerton VR. Enhanced motor function by training in spinal cord contused rats following radiation therapy. PLoS ONE. 2009;4:e6862.","journal-title":"PLoS ONE"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01262-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01262-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01262-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:08:25Z","timestamp":1792012105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01262-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1038\/s41393-026-01262-6","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The animals were purchased and housed according to general guidelines on protecting animals used for scientific purposes (EU Directives 201\/63\/EU). The Ethical Committee for Animal Experiments of Hasselt University approved the animal experiments.","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}